Skip to main content

How does Dexycu work to treat inflammation associated with cataract surgery?

Medically reviewed by Last updated on Feb 16, 2023.

Official answer


Dexycu contains dexamethasone, which is a corticosteroid that prevents the release of substances in the body that cause inflammation.

Dexycu (dexamethasone) from Icon Bioscience Inc., is an injectable, long-acting, corticosteroid intraocular suspension administered into the posterior (rear) chamber of the eye to lower inflammation (swelling) after cataract surgery. Dexycu is given as a single injection at the conclusion of surgery.

What is the advantage of Dexycu injection over eye drops?

Because Dexycu is given as a single, long-acting injection after cataract surgery, patients would not need to self-administer anti-inflammatory eye drops several times daily over a period of weeks after eye surgery. This may be especially advantageous in older patients, and lower the risk of non-compliance and dosing errors linked with frequent eye drops following cataract surgery. However, other eye drops, such as antibiotics, may be needed after cataract surgery.

Related medical questions

Drug information

Related support groups